EFFECT OF TENAPANOR ON SERUM FIBROBLAST GROWTH FACTOR 23 LEVELS

被引:0
|
作者
Block, Geoffrey A. [1 ]
Rosenbaum, David P. [2 ]
Yan, Andrew [2 ]
Greasley, Peter J. [3 ]
Wolf, Myles [4 ]
机构
[1] Denver Nephrol, Denver, CO USA
[2] Ardelyx Inc, Fremont, CA USA
[3] AstraZeneca, Molndal, Sweden
[4] Duke Univ, Durham, NC USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
273
引用
收藏
页码:A85 / A85
页数:1
相关论文
共 50 条
  • [41] Fibroblast growth factor 23 levels decline following sleeve gastrectomy
    Billington, Emma O.
    Murphy, Rinki
    Gamble, Greg D.
    Callon, Karen
    Davies, Naomi
    Plank, Lindsay D.
    Booth, Michael
    Reid, Ian R.
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 87 - 93
  • [42] Fibroblast growth factor 23 levels before and after renal transplantation
    Mohamed M. El-khatib
    Amal R. El-Shahaby
    Sahier O. EEl-Khashab
    Eman El. Mohamed
    Amr M. Shaker
    The Egyptian Journal of Internal Medicine, 2016, 28 (2) : 52 - 59
  • [43] Urine fibroblast growth factor 23 levels in hypertensive children and adolescents
    Zajac, Magdalena
    Rybi-Szuminska, Agnieszka
    Wasilewska, Anna
    CROATIAN MEDICAL JOURNAL, 2015, 56 (04) : 344 - 350
  • [44] Heparin Variants Differ in Their Effect on Fibroblast Growth Factor 23 and Fibroblast Growth Factor Receptor 4 Binding
    Thomas, Madison
    Yanucil, Christopher
    Li, Qing
    Heitman, Kylie
    Fajol, Abul
    Komarova, Svetlana
    Faul, Christian
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [45] Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
    Shubei Zheng
    Yan Chen
    Yu Zheng
    Zhihong Zhou
    Zhanyuan Li
    European Journal of Medical Research, 23
  • [46] Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
    Zheng, Shubei
    Chen, Yan
    Zheng, Yu
    Zhou, Zhihong
    Li, Zhanyuan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2018, 23
  • [47] Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes
    Natsuki, Yuka
    Morioka, Tomoaki
    Kakutani, Yoshinori
    Yamazaki, Yuko
    Ochi, Akinobu
    Kurajoh, Masafumi
    Mori, Katsuhito
    Imanishi, Yasuo
    Shoji, Tetsuo
    Inaba, Masaaki
    Emoto, Masanori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (12) : 1838 - 1848
  • [48] Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation
    Mizia-Stec, Katarzyna
    Wieczorek, Joanna
    Polak, Mateusz
    Wybraniec, Maciej T.
    Wozniak-Skowerska, Iwona
    Hoffmann, Andrzej
    Nowak, Seweryn
    Wikarek, Maria
    Wnuk-Wojnar, Anna
    Chudek, Jerzy
    Wiecek, Andrzej
    CYTOKINE, 2018, 111 : 106 - 111
  • [49] Transition of Serum Fibroblast Growth Factor-23 Levels in Recipients with Renal Osteopathy after Renal Transplantation
    Tokumoto, Tadahiko
    Nozaki, Taishi
    Kazuhiko, Kazuhiko
    Chikaraishi, Kosuke
    Toda, Naohiro
    Akiba, Takashi
    Tanabe, Kazunari
    BLOOD PURIFICATION, 2009, 28 (04) : 320 - 320
  • [50] High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
    Jean, Guillaume
    Terrat, Jean-Claude
    Vanel, Thierry
    Hurot, Jean-Marc
    Lorriaux, Christie
    Mayor, Brice
    Chazot, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) : 2792 - 2796